Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
Fri, June 21, 2024
[ 12:00 AM ] - WOPRAI
Wed, April 3, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, December 14, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 15, 2023
[ 12:00 AM ] - WOPRAI
Mon, October 23, 2023
[ 12:00 AM ] - WOPRAI
Tue, October 3, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 11, 2023
[ 12:00 AM ] - WOPRAI
Wed, June 7, 2023
[ 12:00 AM ] - WOPRAI
Fri, June 2, 2023
[ 12:00 AM ] - WOPRAI
Thu, March 23, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 7, 2023
[ 12:00 AM ] - WOPRAI
Tue, January 10, 2023
[ 12:00 AM ] - WOPRAI
Thu, January 5, 2023
[ 12:00 AM ] - WOPRAI
Fri, December 16, 2022
[ 12:00 AM ] - WOPRAI
Mon, December 12, 2022
[ 12:00 AM ] - WOPRAI
Wed, November 23, 2022
[ 12:00 AM ] - WOPRAI
Thu, November 10, 2022
[ 12:00 AM ] - WOPRAI
Mon, May 23, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 13, 2022
[ 12:00 AM ] - WOPRAI
Wed, May 11, 2022
[ 12:00 AM ] - WOPRAI
Mon, January 3, 2022
[ 12:00 AM ] - WOPRAI
Mon, November 29, 2021
Edward Tenthoff Reiterated (SYRS) at Buy with Decreased Target to $5 on, Aug 13th, 2024
Edward Tenthoff of Piper Sandler, Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Decreased Target from $13 to $5 on, Aug 13th, 2024.
Edward, nor any peers, have made any analyst calls on SYRS in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources